Early pelvic floor physical therapy after pelvic radiation for cervical cancer
Official title: Early Pelvic Floor Physical Therapy for Women Undergoing Pelvic Radiation for Gynecologic Malignancies
Run by University of Cincinnati · NCT07447895 · Data updated 2026-11-12
This will try pelvic floor physical therapy starting four weeks after pelvic radiation to see if it lowers fecal incontinence in women treated for cervical cancer.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 28 (estimated) |
| Sponsor | University of Cincinnati Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Cincinnati, Ohio) |
| Status | Recruiting |
| Started | April 16, 2026 |
| Main results expected | April 16, 2029 |
| Study ends | April 16, 2030 |
| Registry record updated | April 23, 2026 |
| Trial ID | NCT07447895 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Women aged 18 or older with invasive cervical cancer planned for definitive pelvic external beam chemoradiation (minimum 45 Gy) who are willing to undergo pelvic floor physical therapy and can attend in-person visits in English.
✕Probably not a fit
Patients with prior therapeutic pelvic radiation or those who cannot attend in-person, English-language pelvic floor physical therapy sessions would not be eligible and are unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This single-arm Phase II study will enroll 28 women receiving definitive pelvic external beam radiation (minimum 45 Gy) with chemoradiation for invasive cervical cancer. Participants will begin pelvic floor physical therapy four weeks after completing radiation and will be followed for outcomes. The primary endpoint is the rate of fecal incontinence at three months after radiation measured by the EORTC QLQ-CX24, with any score of 1 or higher classified as incontinence. The trial excludes patients with prior therapeutic pelvic radiation and non-English speakers and is conducted at the University of Cincinnati.
Why it matters
Potential benefit: If successful, early pelvic floor physical therapy could reduce post-radiation fecal incontinence and improve bowel-related quality of life for affected patients.
How similar studies have gone: Pelvic floor physical therapy has demonstrated benefit for other pelvic floor disorders, but there is limited prior data specifically testing early therapy after pelvic radiation, so this application is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Participants must be female. 2. Patients must be 18 years old or older. 3. Any patient with invasive cervical cancer who is planned for definitive chemoradiation. 4. Plan to receive a minimum dose of 45Gy to pelvis per investigator. 5. Willing to undergo pelvic floor physical therapy. Exclusion Criteria: 1. Any previous therapeutic pelvic radiation. 2. Non-English speaking.
Where it's running
-
University of Cincinnati
Cincinnati, Ohio, United States Recruiting
Study contacts
- Study coordinator: UCCC Clinical Trials Office
- Email: cancer@uchealth.com
- Phone: 513-584-7698
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Cervical screening and care options for women living with HIV who test positive for high-risk HPV
This study tests different ways to screen and manage high-risk HPV in women with HIV to see what might work best for them.
-
Hydrogel spacer to protect the rectum during cervical cancer radiotherapy
This study tests whether placing an absorbable hydrogel spacer between the cervix/vagina and rectum before definitive radiotherapy can reduce rectal radiation exposure for women with cervical cancer.
-
How cinema sessions during chemotherapy might help cervical cancer patients
We’re testing if watching films during chemotherapy helps cervical cancer patients feel less anxious and improve quality of life.
-
One-Finger Technique to identify the left upper ureter during para-aortic lymphadenectomy
This study tests a new surgical method to help surgeons find the left upper ureter during open para-aortic lymphadenectomy in women with gynecologic cancers.
-
Radiotherapy for gynecologic cancer with up to 10 metastatic sites
This registry follows adults with gynecologic cancer who have 1 to 10 active metastatic lesions and are treated with radiotherapy as part of routine care to see how such treatments work in real-world settings.
-
Stellate ganglion block and dexmedetomidine for better sleep after gynecologic laparoscopy
The study tests whether giving a preoperative stellate ganglion block plus intraoperative dexmedetomidine improves sleep after laparoscopic gynecologic surgery in women.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.